Charles Shi
About Charles Shi
Charles Shi is an Associate Analyst in Biotechnology at Orbimed, where he has worked since 2015. He holds a Doctor of Philosophy from Weill Medical College of Cornell University and has prior experience as a doctoral student in immunology at Memorial Sloan Kettering Cancer Center.
Work at OrbiMed Advisors
Charles Shi has been serving as an Associate Analyst in the Biotechnology sector at OrbiMed Advisors since 2015. In this role, he focuses on analyzing biotechnology investments and market trends. His experience at OrbiMed, based in New York, has allowed him to contribute to the firm's insights and strategies in the rapidly evolving biotech landscape.
Education and Expertise
Charles Shi earned his Doctor of Philosophy degree from the Joan & Sanford I. Weill Medical College of Cornell University, where he studied from 2006 to 2011. Prior to this, he completed a Bachelor of Science degree at Sun Yat-sen University from 2001 to 2005. His educational background provides a strong foundation in the scientific principles relevant to biotechnology and immunology.
Background
Before joining OrbiMed Advisors, Charles Shi worked at Memorial Sloan Kettering Cancer Center as a doctoral student in immunology from 2007 to 2011. This experience allowed him to gain valuable insights into cancer research and immunological processes, which inform his current analytical work in biotechnology.
Professional Experience
Charles Shi has accumulated significant experience in the biotechnology field over the years. His tenure at OrbiMed Advisors, alongside his previous role at Memorial Sloan Kettering Cancer Center, has equipped him with a comprehensive understanding of both investment analysis and scientific research in biotechnology.